Inovio Pharmaceuticals (NYSE:INO) has seen a 22.31% increase in its short percent of float since the last report, with 1.74 million shares sold short, representing 7.73% of available shares. This indicates a bearish sentiment among traders, although it's below the peer group average of 8.32%. The rise in short interest doesn't necessarily predict a price drop but suggests increased bearish activity.